by Louise GagnonApr 3, 20184 min readPsoriasis: Long term studies of biologics demonstrate benefits are maintained over timeThe availability of treatments like brodalumab and guselkumab in the u.S. in 2017, and the anticipated commercial availability of these...
by Emily Innes-Leroux, Associate EditorSep 15, 20164 min readApremilast in combo with other Txs effective for plaque psoriasisCanadian investigators have determined that apremilast—an oral phosphodiesterase 4 inhibitor—can be safely and effectively combined with...